Literature DB >> 28913862

The effect of neuromuscular blockade on the efficiency of facemask ventilation in patients difficult to facemask ventilate: a prospective trial.

S Soltész1, P Alm1, A Mathes2, M Hellmich3, J Hinkelbein2.   

Abstract

Facemask ventilation of the lungs can be an important rescue intervention in a 'cannot intubate' scenario. We assessed the effect of neuromuscular blockade on expiratory tidal volumes in patients with expected difficulty in mask ventilation. The lungs of patients with at least three predictors of difficulty in mask ventilation were ventilated using a facemask held with two hands, with mechanical ventilation set in a pressure-controlled mode. Tidal volumes were recorded before and after the establishment of complete neuromuscular block. In 113 patients, median (IQR [range]) tidal volume increased from 350 (260-492 [80-850]) ml initially, by 48% to 517 (373-667 [100-1250]) ml 30 s after rocuronium administration, (p < 0.001). After the onset of the complete neuromuscular block, a median tidal volume of 600 (433-750 [250-1303]) ml was observed, corresponding to an increase of 71% from baseline values (p < 0.001), and 16% from values obtained 30 s after rocuronium administration, respectively; p = 0.003). No decrease in the tidal volume during the measurements was observed. We conclude that the administration of rocuronium at a dose of 0.6 mg.kg-1 was able to improve facemask ventilation in all cases with a potentially clinically relevant increase in tidal volume. The early use of a neuromuscular blocking agent can be considered as a therapeutic option in case of difficulty with mask ventilation.
© 2017 The Association of Anaesthetists of Great Britain and Ireland.

Entities:  

Keywords:  difficult ventilation; facemask ventilation; neuromuscular blocking agents

Mesh:

Substances:

Year:  2017        PMID: 28913862     DOI: 10.1111/anae.14035

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  6 in total

1.  Suxamethonium or rocuronium for rapid sequence induction of anaesthesia?

Authors:  W J Fawcett
Journal:  BJA Educ       Date:  2019-10-22

2.  [Neuromuscular residual block : Unavoidable risk or reliably treatable?]

Authors:  T Fuchs-Buder
Journal:  Anaesthesist       Date:  2019-11       Impact factor: 1.041

3.  [Influence of rocuronium dose on the effectiveness of mask ventilation : A prospective, randomized clinical trial].

Authors:  M Hellmund; J Bajorat; S Machmüller; M Sauer; A Zitzmann; D A Reuter; T Mencke
Journal:  Anaesthesist       Date:  2018-05-25       Impact factor: 1.041

4.  Rocuronium versus saline for effective facemask ventilation during anesthesia induction: a double-blinded randomized placebo-controlled trial.

Authors:  Akira Ide; Natsuko Nozaki-Taguchi; Shin Sato; Kei Saito; Yasunori Sato; Shiroh Isono
Journal:  BMC Anesthesiol       Date:  2022-06-03       Impact factor: 2.376

5.  Canadian Airway Focus Group updated consensus-based recommendations for management of the difficult airway: part 2. Planning and implementing safe management of the patient with an anticipated difficult airway.

Authors:  J Adam Law; Laura V Duggan; Mathieu Asselin; Paul Baker; Edward Crosby; Andrew Downey; Orlando R Hung; George Kovacs; François Lemay; Rudiger Noppens; Matteo Parotto; Roanne Preston; Nick Sowers; Kathryn Sparrow; Timothy P Turkstra; David T Wong; Philip M Jones
Journal:  Can J Anaesth       Date:  2021-06-08       Impact factor: 5.063

6.  Canadian Airway Focus Group updated consensus-based recommendations for management of the difficult airway: part 1. Difficult airway management encountered in an unconscious patient.

Authors:  J Adam Law; Laura V Duggan; Mathieu Asselin; Paul Baker; Edward Crosby; Andrew Downey; Orlando R Hung; Philip M Jones; François Lemay; Rudiger Noppens; Matteo Parotto; Roanne Preston; Nick Sowers; Kathryn Sparrow; Timothy P Turkstra; David T Wong; George Kovacs
Journal:  Can J Anaesth       Date:  2021-06-18       Impact factor: 5.063

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.